🔎 Trials Near Me

Beranda › Kanker Payudara › California › Sacramento

Uji klinis Kanker Payudara di Sacramento, CA

20 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Sacramento (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Menerima pesertaFase 3
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Menerima pesertaFase 3
  • Sutter Inst Medical Research, Sacramento
  • School Of Medicine, Sacramento
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05827081

Distance-Based Exercise to Preserve Function and Prevent Disability

Menerima peserta
  • Kaiser Permanente-South Sacramento, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Menerima pesertaSukarelawan sehat diterima
  • University of California Davis, Sacramento
Usia 30 hingga 74 · Wanita · Diperbarui 21 Sep 2026 · NCT02620852

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Menerima pesertaFase 3
  • University Of California Davis Health System, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07173751

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

Menerima pesertaStudi observasional
  • UC Davis, Sacramento
Usia 18 hingga 94 · Wanita · Diperbarui 17 Sep 2026 · NCT07505797

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Menerima pesertaFase 3
  • Dignity Health dba Health Research Institute, Sacramento
  • Sutter Institute for Medical Research, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06492616

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Menerima pesertaFase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • dan 5 lainnya
Usia 18 hingga 60 · Wanita · Diperbarui 2 Sep 2026 · NCT05879926

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

Menerima pesertaSukarelawan sehat diterima
  • University of California, Davis, Sacramento
Usia 25 ke atas · Wanita · Diperbarui 1 Sep 2026 · NCT03729115

E-Mindfulness Approaches for Living After Breast Cancer

Menerima pesertaFase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06748222

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

Menerima peserta
  • University of California, Davis, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT06103669

UHFUS Characterization of Normal Lymphatic Anatomy

Menerima peserta
  • University of California Davis Health, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT07677839

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Menerima pesertaFase 2
  • University of California - Davis, Comprehensive Cancer Center, Davis · 14 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT01042379

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Menerima pesertaFase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • dan 4 lainnya
Usia 50 hingga 70 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT04852887

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Apr 2026 · NCT05785741

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Menerima pesertaFase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mar 2026 · NCT06268665

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Menerima pesertaFase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863

Uji klinis Kanker Payudara di kota lain

Studi lain di Sacramento

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.